Company Overview: Aytu BioScience

Industry News

14 Mar

Aytu BioScience Announces Peer-Reviewed Publication of Fourth Clinical Study Demonstrating the Utility of MiOXSYS® in the Assessment of Male Infertility

ENGLEWOOD, Colo., March 14, 2017 /PRNewswire/ — Aytu BioScience, Inc. (AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced the publication of a peer-reviewed journal article demonstrating the clinical utility of the Company’s MiOXSYS® System for assessing the level of...

Read more

1 Feb

Aytu BioScience Announces Two Presentations at Endocrine Society 2017 Annual Meeting Highlighting Benefits of Natesto® (Testosterone) Nasal Gel in Men

ENGLEWOOD, Colo., Feb. 1, 2017 /PRNewswire/ — Aytu BioScience, Inc. (AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced that two posters demonstrating clinical data for Natesto® (testosterone) Nasal Gel were accepted for presentation at the Endocrine Society 2017 Annual...

Read more

24 Jan

Aytu BioScience to Present at Noble Capital Markets’ 13th Annual Investor Conference

ENGLEWOOD, Colo., Jan. 24, 2017 /PRNewswire/ — Aytu BioScience, Inc. (AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced that Josh Disbrow, Chairman & Chief Executive Officer, and Jarrett Disbrow, Chief Operating Officer, will present a corporate overview at NobleCon13...

Read more

18 Jan

Aytu BioScience Announces Two Presentations Highlighting Benefits of Natesto® (Testosterone) Nasal Gel in Men at American Urological Association Annual Meeting

ENGLEWOOD, Colo., Jan. 18, 2017 /PRNewswire/ — Aytu BioScience, Inc. (AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced that two posters demonstrating clinical data for Natesto® (testosterone) Nasal Gel were accepted for presentation at the American Urological Association 2017...

Read more

4 Jan

Aytu BioScience to Present at Biotech Showcase 2017 Investor Conference

ENGLEWOOD, Colo., Jan. 4, 2017 /PRNewswire/ — Aytu BioScience, Inc. (AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced that Josh Disbrow, Chairman & Chief Executive Officer, and Jarrett Disbrow, Chief Operating Officer, will present a corporate overview at the...

Read more

15 Dec

Aytu BioScience Launches Asian Distribution Network for Company’s MiOXSYS® System for Male Infertility

ENGLEWOOD, Colo., Dec. 15, 2016 /PRNewswire/ — Aytu BioScience, Inc. (AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced that it has entered into agreements with five leading Asian specialty medical distributors to commercialize the Company’s MiOXSYS® System. MiOXSYS is...

Read more

5 Dec

Aytu Bioscience Presentation Now Available for On-Demand Viewing

ENGLEWOOD, Colo., Dec, 5, 2016 /PRNewswire/ — Aytu Bioscience Inc. (AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced that the December 1 presentation from Chief Executive Officer Josh Disbrow, is now available for on-demand viewing at VirtualInvestorConferences.com. Aytu Bioscience’s...

Read more

Page 1 of 212

Enter your email address to receive notifications of new posts by email.

Latest Tweets

Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address